Sep 9, 2026 07:28AM

Sep 8, 2026 01:25PM

Sep 8, 2026 10:53AM

Aug 5, 2026 04:35PM

Jul 28, 2026 06:44AM

Jul 27, 2026 08:30AM

Jul 8, 2026 05:08PM Wolfe Research Upgrades Sarepta Therapeutics (SRPT) to Outperform

Jul 1, 2026 06:58AM

Jun 30, 2026 11:00AM

Jun 30, 2026 08:30AM

Jun 18, 2026 06:11AM

May 6, 2026 04:46PM

Apr 17, 2026 06:46AM

Mar 27, 2026 07:00PM This stock's bull case is 'clearly stronger today than yesterday': analyst

Mar 26, 2026 06:39AM

Mar 25, 2026 04:04PM

Mar 25, 2026 03:05PM

Mar 25, 2026 03:02PM

Mar 25, 2026 10:46AM

Mar 25, 2026 10:43AM

Mar 25, 2026 10:33AM Leerink Partners on Sarepta Therapeutics (SRPT): siRNA data 'a bit of a mixed bag'

Mar 25, 2026 10:32AM

Mar 25, 2026 08:05AM

Mar 19, 2026 11:11AM

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM

Mar 17, 2026 07:37AM

Mar 16, 2026 08:34AM Sarepta begins enrollment for enhanced safety protocol in gene therapy study

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM

Mar 3, 2026 03:44PM

Mar 3, 2026 12:00PM

Mar 2, 2026 06:47AM

Feb 26, 2026 08:30AM

Feb 25, 2026 04:45PM Sarepta Therapeutics (SRPT) Misses Q4 EPS by 237c

Feb 24, 2026 09:08AM

Feb 4, 2026 08:30AM

Jan 27, 2026 06:43AM

Jan 26, 2026 12:54PM

Jan 26, 2026 08:01AM

Jan 26, 2026 05:30AM

Jan 26, 2026 05:18AM RBC Capital on Sarepta (SRPT): 'KOL Feedback Suggests Elevidys Use Unlikely To Pick Back Up in '26'

Jan 23, 2026 04:05PM

Jan 14, 2026 06:55AM

Jan 14, 2026 04:39AM

Jan 12, 2026 11:59AM

Jan 12, 2026 09:30AM

Jan 8, 2026 03:59AM

Jan 7, 2026 08:31AM Sarepta submits clinical trial application for Huntington's disease drug

Dec 11, 2025 11:53AM

460,593 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All